You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.



Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius

This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs

read more 


Hemophilia seen through children's eyes: Kedrion teams up with LA Kelley

Three books of the series My First Factor Creation are now available for free download

read more 


SIPPET study results published in the “New England Journal of Medicine”

This investigator-initiated clinical study involved 42 hemophilia treatment centers from all over the world

read more 
  1. EVENTS - 13-07-2015

    Revolutionary PID testing from Tuscany, Italy

    Kedrion at Meyer Hospital’s side to promote early diagnosis of primary immunodeficiencies

    read more 
  2. CORPORATE - 13-07-2015

    Humanitarian programme to reduce the gap in the access to clotting factors

    Kedrion helps the WISH project come true: Italian CNS and the World Federation of Hemophilia sign agreement in London

    read more 
  3. EVENTS - 18-12-2014

    Article on present and future of the LASID sponsored by Kedrion

    Published by the Elsevier Group, it has been handed out at PID Congress in Guanajuato, México

    read more 
  4. PLASMA & BIOTHERAPIES - 30-08-2014

    Kedrion announces the launch of Plasmaclot™ on the Mexican market

    Kedrion launches Plasmaclot™ in Mexico. Plasma-derived coagulation factor treats hemophilia A

    read more 


For more information please contact: